Stoke Therapeutics launches up to $200M at-the-market offering of common stock at $28.86/share

Filed August 3, 2026 · ~2 min read

Key Changes

• high

  Stoke Therapeutics may sell up to $200 million of common stock from time to time through Cantor Fitzgerald in an at-the-market offering.

  The Offering verify on EDGAR →
• high

  The offering price is $28.86 per share, the last reported sale price on Nasdaq on July 31, 2026; actual sale prices will vary.

  The Offering verify on EDGAR →
• high

  New investors face immediate dilution of $21.05 per share, as net tangible book value per share rises from $5.54 to $7.81 after the offering.

  Dilution verify on EDGAR →